Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients

Publisher： John Wiley & Sons Inc

E-ISSN： 2190-6009|6|1|53-61

ISSN： 2190-5991

Source： Journal Of Cachexia Sarcopenia And Muscle, Vol.6, Iss.1, 2015-03, pp. : 53-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differentially expressed alternatively spliced genes in skeletal muscle from cancer patients with cachexia

By  

Journal Of Cachexia Sarcopenia And Muscle, Vol. 9, Iss. 1, 2018-02 ,pp. : 60-70

John Wiley & Sons Inc

Access to resources Recommend Favorite

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training

By  

Journal Of Cachexia Sarcopenia And Muscle, Vol. 6, Iss. 3, 2015-09 ,pp. : 197-207

John Wiley & Sons Inc

Access to resources Recommend Favorite

What We Have Learned about Cachexia in Gastrointestinal Cancer

By  

Digestive Diseases, Vol. 21, Iss. 3, 2003-10 ,pp. : 198-213

Karger

Access to resources Recommend Favorite

Established and Potential Predictive Biomarkers in Gastrointestinal Cancer - c-Kit, Her2, Ras and Beyond

By  

Digestion, Vol. 91, Iss. 4, 2015-04 ,pp. : 294-302

Karger

Access to resources Recommend Favorite

Lactulose Is Highly Potential in Prophylaxis of Hepatic Encephalopathy in Patients with Cirrhosis and Upper Gastrointestinal Bleeding: Results of a Controlled Randomized Trial

By  

Digestion, Vol. 87, Iss. 2, 2013-03 ,pp. : 132-138

Karger

Access to resources Recommend Favorite